Kipp Weiskopf

Hadassah Medical Center — Israel

Immunology and Microbiology · Life Sciences

28h-index8.0kcitations102works2.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Phagocytosis and Immune Regulation(55), Monoclonal and Polyclonal Antibodies Research(24), Immune Cell Function and Interaction(19), Immune cells in cancer(19), Erythrocyte Function and Pathophysiology(16)

Publications101 total

Haruka Resolves Perturbation Response Heterogeneity in Spatial Cell Niches
2025Open Access
1202 Rapid discovery and development of antibodies that provoke macrophages to eliminate gastroesophageal cancer
Regular and Young Investigator Award Abstracts·2025Open Access
Inflammation awakens dormant cancer cells by modulating the epithelial–mesenchymal phenotypic state
Proceedings of the National Academy of Sciences·2025· 1 citedOpen Access
CD47 predominates over CD24 as a macrophage immune checkpoint in cancer
2024· 2 citedOpen Access
Unbiased discovery of antibody therapies that stimulate macrophage-mediated destruction of B-cell lymphoma
2024· 1 citedOpen Access
Abstract A055: CD47 predominates over CD24 as a macrophage immune checkpoint in cancer
Cancer Immunology Research·2024
Abstract PO-038: Unbiased discovery of novel antibody therapies that stimulate macrophage-mediated destruction of B-cell lymphoma
Blood Cancer Discovery·2024
Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction
Journal of Clinical Investigation·2024· 16 citedOpen Access
Phagocytic cooperativity by tumour macrophages
Nature Biomedical Engineering·2023· 4 cited
MMD collaborates with ACSL4 and MBOAT7 to promote polyunsaturated phosphatidylinositol remodeling and susceptibility to ferroptosis
Cell Reports·2023· 49 citedOpen Access
Supplementary Tables 1 through 3, Supplementary Figure Legends, and Supplementary Materials and Methods from Eradication of Canine Diffuse Large B-Cell Lymphoma in a Murine Xenograft Model with CD47 Blockade and Anti-CD20
2023Open Access
Supplementary Figure S5 from Eradication of Canine Diffuse Large B-Cell Lymphoma in a Murine Xenograft Model with CD47 Blockade and Anti-CD20
2023Open Access
Data from Eradication of Canine Diffuse Large B-Cell Lymphoma in a Murine Xenograft Model with CD47 Blockade and Anti-CD20
2023Open Access
Supplementary Tables 1 through 3, Supplementary Figure Legends, and Supplementary Materials and Methods from Eradication of Canine Diffuse Large B-Cell Lymphoma in a Murine Xenograft Model with CD47 Blockade and Anti-CD20
2023Open Access
Supplementary Figure S2 from Eradication of Canine Diffuse Large B-Cell Lymphoma in a Murine Xenograft Model with CD47 Blockade and Anti-CD20
2023Open Access
Supplementary Figure S4 from Eradication of Canine Diffuse Large B-Cell Lymphoma in a Murine Xenograft Model with CD47 Blockade and Anti-CD20
2023Open Access
Supplementary Figure S7 from Eradication of Canine Diffuse Large B-Cell Lymphoma in a Murine Xenograft Model with CD47 Blockade and Anti-CD20
2023Open Access
Supplementary Figure S5 from Eradication of Canine Diffuse Large B-Cell Lymphoma in a Murine Xenograft Model with CD47 Blockade and Anti-CD20
2023Open Access
Supplementary Figure S4 from Eradication of Canine Diffuse Large B-Cell Lymphoma in a Murine Xenograft Model with CD47 Blockade and Anti-CD20
2023Open Access
Supplementary Figure S2 from Eradication of Canine Diffuse Large B-Cell Lymphoma in a Murine Xenograft Model with CD47 Blockade and Anti-CD20
2023Open Access
page 1 of 6Next →

Frequent Co-authors

Irving L. Weissman(27), Aaron M. Ring(14), Peter J. Schnorr(9), Ronald Levy(9), Stephen B. Willingham(8), Jens-Peter Volkmer(8), Roch Houot(8), Anne Kathrin Volkmer(7), Matt van de Rijn(7), K. Christopher García(7), Holbrook E. Kohrt(7), Debra K. Czerwinski(7), Lieping Chen(7), Ravindra Majeti(6), A. Dimitrios Colevas(6), Ferenc A. Scheeren(5), Mark P. Chao(5), Badreddin Edris(5), John B. Sunwoo(5), Matthew J. Goldstein(5)